64X BIO
64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery. The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specific focus on those used for cell and gene therapies.
64X BIO
Industry:
Biopharma Biotechnology Genetics Life Science Pharmaceutical
Founded:
2017-08-22
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.64xbio.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
59.5 M USD
Technology used in webpage:
IPv6 Google Apps For Business Google Google DNS Google Domains Google Cloud DNS
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Arctoris
Arctoris is a tech-enabled platform company in biotechnology, combining robotics & data science to accelerate drug discovery.
Castle Creek Biosciences
Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Advisors List
Current Employees Featured
Founder
Investors List
Michael Chambers
Michael Chambers investment in Series A - 64x Bio
Liquid 2 Ventures
Liquid 2 Ventures investment in Series A - 64x Bio
BoxGroup
BoxGroup investment in Series A - 64x Bio
Chris Gibson
Chris Gibson investment in Series A - 64x Bio
Refactor Capital
Refactor Capital investment in Series A - 64x Bio
Alix Ventures
Alix Ventures investment in Series A - 64x Bio
Lifeforce Capital
Lifeforce Capital investment in Series A - 64x Bio
First Round Capital
First Round Capital investment in Series A - 64x Bio
Northpond Ventures
Northpond Ventures investment in Series A - 64x Bio
Milad Alucozai
Milad Alucozai investment in Series A - 64x Bio
Newest Events participated
Official Site Inspections
http://www.64xbio.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "64x Bio"
64x Bio
Using novel high throughput genome engineering and screening technologies in a design loop with computational tools, 64x Bio is developing new ways of generating highly optimized and …See details»
64x Bio - Crunchbase Company Profile & Funding
64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery. The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of …See details»
Team - 64x Bio
We are a cross disciplinary and growing collaborative team with a mission to develop novel technologies that will help bring more cell and gene therapies to patients.See details»
64x Bio Company Profile 2024: Valuation, …
64x Bio was founded in 2017. Where is 64x Bio headquartered? 64x Bio is headquartered in Brisbane, CA. What is the size of 64x Bio? 64x Bio has 21 total employees. What industry is 64x Bio in? 64x Bio’s primary industry is Drug …See details»
64x Bio - Y Combinator
High throughput design of cells for therapeutics applications. 64x Bio is building a platform that radically increases the speed and scale of mammalian cell line discovery.See details»
64x Bio - LinkedIn
High throughput engineering of cell lines to enhance the design and manufacture of next-generation therapeutics. Academic innovators have driven groundbreaking technologies like CRISPR, gene...See details»
Contact - 64x Bio
© 2024 64x Bio. All rights reserved. bottom of pageSee details»
64x Bio Company Profile - Office Locations, Competitors
64x Bio (formerly 64-x) is a biotech company that engineers microorganisms with enhanced properties. It is engaged in designing and building bacterial genomes for applications in …See details»
64x Bio - VentureRadar
Website: https://www.64xbio.com/ Develops a platform for accelerating mammalian cell line discovery using high throughput genome engineering, focusing on cell and gene therapies, to …See details»
Alix Ventures — 64x Bio
“64x Bio, a spinout of Harvard’s Wyss Institute and George Church's lab, is transforming the future of cell and gene therapy manufacturing.See details»
64x Bio Raises $55 Million Series A Financing to Advance …
Jan 19, 2022 · SAN FRANCISCO-- ( BUSINESS WIRE )-- 64x Bio, a synthetic biology company, today announced the close of a $55 million Series A financing round to fund the expansion of …See details»
Lexi Rovner - Co-founder & CEO - 64x Bio
2024 Founder-led Biotech Tour starts next week. Co-hosted with 80+ founders. 4 global hubs. One mission: accelerate biotech innovation. SF:… It was awesome coming back to Stanford University to...See details»
64x Bio - workinbiotech.com
To develop and manufacture cell therapies, cell lines that are easy to manipulate, engineer and grow are required. 64x Bio is using their VectorSelect platform to generate highly optimized …See details»
64x Bio Raises $55 Million to Advance Cell Line …
Jan 19, 2022 · Synthetic biology company 64x Bio raised $55 million in a series A financing round to fund the expansion of its VectorSelect platform, a novel cell line engineering technology that …See details»
64x Bio Emerges from Stealth to Drive an Evolution in Cell …
Nov 16, 2020 · SAN FRANCISCO-- ( BUSINESS WIRE )--64x Bio announced today that they are emerging from stealth and are describing for the first time their proprietary VectorSelect TM …See details»
Pitch Deck: 64x Bio Raises $55 Million for Cell, Gene …
Jan 19, 2022 · New therapies that target cells and genes are growing in popularity, but face manufacturing issues. A new startup, 64xBio, wants to improve how these treatments are …See details»
64x Bio Emerges from Stealth to Drive an Evolution in Cell …
Nov 18, 2020 · The novel approach developed by founders at Harvard and the Wyss Institute of Biologically Inspired Engineering promises to bring more cell and gene therapies to patients. …See details»
64x Bio Emerges from Stealth to Drive an Evolution in Cell …
Nov 16, 2020 · SAN FRANCISCO-- ( BUSINESS WIRE )-- 64x Bio announced today that they are emerging from stealth and are describing for the first time their proprietary VectorSelect TM …See details»
64x Bio Emerges from Stealth to Drive an Evolution in Cell …
Nov 17, 2020 · 64x Bio announced today that they are emerging from stealth and are describing for the first time their proprietary VectorSelect TM platform and vision for the company. The …See details»
News - 64x Bio
January 22nd, 2022. 64x Bio's iterative solutions to vector manufacturing pain points . January 19th, 2022. Harvard offshoot 64x Bio nets $55M in series A funding to expand cell production …See details»